Latest VCNX reports update at 2024-05-15: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Vaccinex
  4. Financial Statements
Vaccinex logo
Vaccinex VCNX
$ 5.41 -3.39%
mail-toReport an Error

Vaccinex Financial Statements 2011-2024 | VCNX

Annual Financial Statements Vaccinex

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

 2.75 M 80.8 K 43.6 M 47.4 M 96.6 M 26.2 M - - - - - - -

Shares

 464 K 202 K 28.8 M 20.1 M 12.9 M 5.22 M - - - - - - -

Historical Prices

 5.93 0.4 1.51 2.36 6.95 4.84 - - - - - - -

Net Income

 -20.3 M -19.8 M -22.4 M -28.9 M -31.9 M -29.5 M -18.7 M -13.9 M - - - - -

Revenue

 570 K 275 K 900 K 50 K 523 K 724 K 90 K 316 K - - - - -

Cost of Revenue

 - - - 2 K 199 K 1.03 M 160 K - - - - - -

Gross Profit

 - - - 48 K 324 K -309 K -70 K 201 K - - - - -

Operating Income

 -22.9 M -19.9 M -22.5 M -28.3 M -32 M -27.3 M -21.1 M - - - - - -

Interest Expense

 1 K 2 K 809 K 489 K 152 K 392 K 1.36 M - - - - - -

EBITDA

 -22.8 M -19.7 M -22.3 M -28 M -31.8 M -27.1 M -20.9 M -20.1 M - - - - -

Operating Expenses

 - - - 29 M 32.3 M 27 M 21 M 20.5 M - - - - -

General and Administrative Expenses

 6.88 M 6.2 M 6.23 M 7.4 M 6.67 M 4.62 M 4.48 M 4.43 M - - - - -

All numbers in USD currency

Quarterly Income Statement Vaccinex

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

 1.33 M 893 K 4.51 M 60.4 M 238 K 3.33 M 2.84 M 42.7 M 38.8 M 30.8 M 30.8 M 28.6 M 25.2 M 22.4 M 20.1 M 16.7 M 16 M 14.9 M 13.8 M 11.5 M 11.5 M 11.5 M 7.08 M 1.1 M 1.1 M 1.1 M 1.1 M 1.1 M - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

 -3.9 M - -4.91 M -7.06 M -4.96 M - -4.76 M -5.38 M -4.6 M - -5.21 M -5.97 M -6.57 M - -8.75 M -6.5 M -7.15 M - -7.64 M -8.83 M -9.07 M - -6.6 M -6.61 M -7.86 M - -5.54 M -4.88 M - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

 104 K - 20 K - 550 K - 50 K - - - 50 K 850 K 850 K - 625 K - - - 404 K 25 K 94 K - 198 K 126 K 206 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

 - - - - - - - - - - - - - - 2 K - - - 8 K 16 K 175 K - 246 K 246 K 240 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

 -5.07 M - -5.83 M -7.08 M -4.99 M - -4.79 M -5.4 M -4.59 M - -5.06 M -5.67 M -6.24 M - -8.58 M -6.5 M -7.16 M - -7.68 M -8.86 M -9.14 M - -6.45 M -6.56 M -5.71 M - -5.33 M -4.67 M - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

 -1 K - 922 K - 24 K - 1 K 1 K 1 K - 142 K 351 K 332 K - 148 K -1 K 10 K - 36 K 30 K 73 K - 44 K 81 K 267 K - 361 K 355 K - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

 -5.05 M - -5.8 M -7.05 M -4.96 M - -4.72 M -5.35 M -4.55 M - -5.03 M -5.63 M -6.18 M - -8.51 M -6.41 M -7.08 M - -7.61 M -8.8 M -9.08 M - -6.4 M -6.5 M -5.65 M - -5.28 M 45.3 M - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

 1.8 M - 1.5 M 2.03 M 1.72 M - 1.41 M 1.56 M 1.63 M - 1.48 M 1.6 M 1.58 M - 1.87 M 1.94 M 1.75 M - 1.53 M 1.56 M 1.65 M - 1.09 M 925 K 1.22 M - 1.04 M 1.27 M - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency